| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000020174 |
| Receipt No. | R000023306 |
| Official scientific title of the study | Prospective multicenter trial for efficacy of potassium competitive acid blocker to reduce delayed bleeding after gastric endoscopic submucosal dissection in patients on antithrombotic therapy |
| Date of disclosure of the study information | 2015/12/11 |
| Last modified on | 2018/12/13 (Ver. 6) |
| Basic information | ||
| Official scientific title of the study | Prospective multicenter trial for efficacy of potassium competitive acid blocker to reduce delayed bleeding after gastric endoscopic submucosal dissection in patients on antithrombotic therapy | |
| Title of the study (Brief title) | Preventive effect of P-CAB for postoperative bleeding after gastric ESD | |
| Region |
|
|
| Condition | ||
| Condition | Gastric neoplasm | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To reveal the preventive effect of P-CAB for postoperative bleeding in high-risk patients after gastric ESD |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Post-ESD bleeding rate |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Daily use of Vonoplazan (day 1 - 28) | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. Diagnosis of gastric adenoma or early gastric cancer satisfying the Japanese guideline criteria.
2. On antithrombotic therapy 3. 20 years or older 4. Performance status (ECOG) is 0, 1 or 2 5. With a written informed consent. |
|||
| Key exclusion criteria | 1. History of gastrectomy
2. Schedule of endoscopic treatment for esophageal or duodenal lesion concurrently. 3. History of endoscopic treatment for upper GI lesion in the past 28 days. 4. Schedule of endoscopic treatment for upper GI lesion within 28 days after the gastric ESD. 5. Systemic administration (intravenously or orally) of either one or more drugs of corticosteroid, anticoagulant agent. 6. Diagnosis of psychiatric diseases. 7. With active bacterial or fungus infection. 8. With uncontrollable hypertension. 9. Disqualified for the study by physicians. |
|||
| Target sample size | 50 | |||
| Research contact person | |
| Name of lead principal investigator | Tetsuo Takehara |
| Organization | Osaka university graduate school of medicine |
| Division name | Gastroenterology and hepatology |
| Address | Yamadaoka2-2, Suita, Osaka |
| TEL | 06-6879-5111 |
| takehara@gh.med.osaka-u.ac.jp | |
| Public contact | |
| Name of contact person | Yoshito Hayashi |
| Organization | Osaka university graduate school of medicine |
| Division name | Gastroenterology and hepatology |
| Address | Yamadaoka2-2, Suita, Osaka |
| TEL | 06-6879-5111 |
| Homepage URL | |
| y.hayashi@gh.med.osaka-u.ac.jp | |
| Sponsor | |
| Institute | Osaka Gut Forum (OGF) |
| Institute | |
| Department | |
| Funding Source | |
| Organization | n/a |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000023306 |